TRPV2 and COVID-19: Collectively, our findings identified TRPV2 as a novel receptor of SARS-CoV-2 infection under febrile conditions, providing insight into the critical interactions of SARS-CoV-2 with macrophages, as well as a useful resource and potential drug target for COVID-19 treatment.